KEY FINDINGS Average weight loss on treatment: 7.9 kg (all GLP-1s) 16.1 kg (newer GLP-1s like semaglutide/tirzepatide) Weight regained after stopping: 0.70.8 kg/month 8.39.6 kg regained in the first year Full return to baseline: 0.9 years (older GLP-1s) 1.7 years (newer GLP-1s) Bottom line: GLP-1s are effective, but without ongoing treatment or structured long-term care, the benefits fade quickly
Grasp the factors that influence best dosing helps researchers design effective protocols while keeping appropriate safety margins
If you do qualify for financial assistance, you will need to reapply every 12 months after your initial eligibility
Allergies: Some people with IC have allergies to certain foods or other substances, which may trigger IC symptoms
Abdelzaher WY, Abdel-Gaber SA, Fawzy MA, Ali AHSAB, Attya ME, Geddawy A (2023) Atorvastatin protects against cyclophosphamide-induced thyroid injury in rats via modulation of JNK/ERK/p38 MAPK signaling pathway
